By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OrthoLogic Corporation 

Name change to Capstone Therapeutics
Press releases archived for reference only.
Tempe  Arizona  85281  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: OrthoLogic
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
OrthoLogic Corporation Announces New Company Name: Capstone Therapeutics (CAPS) 10/1/2008 10:02:28 AM
OrthoLogic Corporation (OLGC) Release: AZX100 Pre-Clinical Results Show Reduction of Fibrosis and Scarring; Human Clinical Safety Trials Continuing 9/12/2008 10:40:20 AM
OrthoLogic Corporation (OLGC) Release: Chrysalin (Rusalatide Acetate, TP508) Pre-Clinical Results Show Significant Beneficial Effect in Chronic Heart Disease 9/3/2008 10:44:17 AM
OrthoLogic Corporation (OLGC) Announces Completion of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring 8/14/2008 11:53:44 PM
OrthoLogic Corporation (OLGC) to Present At Fourth Annual Noble Financial Equity Conference August 19, 2008 8/12/2008 11:02:03 PM
OrthoLogic Corporation (OLGC) Receives Nasdaq Notice Letter 8/11/2008 11:16:39 PM
OrthoLogic Corporation (OLGC) Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease 8/7/2008 11:06:27 AM
OrthoLogic Corporation (OLGC) Announces Second Quarter 2008 Financial Results 8/7/2008 11:05:22 AM
OrthoLogic Corporation (OLGC) to Host Conference Call Discussing Second Quarter 2008 Operating Results 7/31/2008 9:53:07 AM
OrthoLogic Corporation (OLGC) Announces Initiation of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring 7/10/2008 9:01:44 AM
123456789
//-->